Clinical Trials
13
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:11
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
11 (84.6%)Phase 2
2 (15.4%)A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT06999083
- Locations
- 🇳🇿
New Zealand Clinical Research , Grafton, Auckland, 3 Ferncroft Street,, Auckland, Grafton, New Zealand
A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors
Phase 1
- Conditions
- Solid Tumors
- Interventions
- Drug: HB0052 Injection
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06992687
- Locations
- 🇨🇳
Peking University Cancer Hospital, Peking, China
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT06895499
- Locations
- 🇨🇳
Dermatology Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06716151
- Locations
- 🇨🇳
Central Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT06612970
- Locations
- 🇳🇿
New Zealand Clinical Research, Christchurch, New Zealand
- Prev
- 1
- 2
- 3
- Next
News
No news found